# Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi

> **NCT01650558** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 1499 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Standard of Care prophylaxis
- **DRUG:** Chloroquine (CQ) prophylaxis

## Key facts

- **NCT ID:** NCT01650558
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 1499 (ACTUAL)
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650558, "Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01650558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*